{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:35:07Z","timestamp":1777631707228,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1053\/j.ajkd.2008.07.023","type":"journal-article","created":{"date-parts":[[2008,9,22]],"date-time":"2008-09-22T04:13:41Z","timestamp":1222056821000},"page":"346-350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Thrombotic Microangiopathy and Renal Failure Exacerbated by \u03b5-Aminocaproic Acid"],"prefix":"10.1053","volume":"53","author":[{"given":"Walter P.","family":"Mutter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isaac E.","family":"Stillman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neera K.","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2008.07.023_bib1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/clpt.1984.48","article-title":"Kinetics of epsilon-aminocaproic acid distribution, elimination, and antifibrinolytic effects in normal subjects","volume":"35","author":"Frederiksen","year":"1984","journal-title":"Clin Pharmacol Ther"},{"key":"10.1053\/j.ajkd.2008.07.023_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5414\/CNP58063","article-title":"Epsilon-aminocaproic acid and renal complications: Case report and review of the literature","volume":"58","author":"Manjunath","year":"2002","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.ajkd.2008.07.023_bib3","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1002\/cncr.20290","article-title":"Gemcitabine-associated thrombotic microangiopathy","volume":"100","author":"Humphreys","year":"2004","journal-title":"Cancer"},{"key":"10.1053\/j.ajkd.2008.07.023_bib4","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1046\/j.1523-1755.2001.060003831.x","article-title":"Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura","volume":"60","author":"Ruggenenti","year":"2001","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2008.07.023_bib5","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1432-2277.2006.00354.x","article-title":"Thrombotic microangiopathy after kidney transplantation","volume":"19","author":"Ponticelli","year":"2006","journal-title":"Transpl Int"},{"key":"10.1053\/j.ajkd.2008.07.023_bib6","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1055\/s-2005-925475","article-title":"Thrombotic microangiopathy in transplantation and malignancy","volume":"31","author":"Qu","year":"2005","journal-title":"Semin Thromb Hemost"},{"key":"10.1053\/j.ajkd.2008.07.023_bib7","first-page":"235","article-title":"Review of thrombotic microangiopathy (TMA), and post-renal transplant TMA","volume":"17","author":"Ardalan","year":"2006","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1053\/j.ajkd.2008.07.023_bib8","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1001\/archinte.1986.00360230069012","article-title":"Thrombosis, recurrent fetal loss, and thrombocytopenia","volume":"146","author":"Harris","year":"1986","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.ajkd.2008.07.023_bib9","first-page":"486","article-title":"The anticardiolipin syndrome","volume":"13","author":"Hughes","year":"1986","journal-title":"J Rheumatol"},{"key":"10.1053\/j.ajkd.2008.07.023_bib10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.7326\/0003-4819-117-4-303","article-title":"Antiphospholipid thrombosis: Clinical course after the first thrombotic event in 70 patients","volume":"117","author":"Rosove","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.ajkd.2008.07.023_bib11","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJM199504133321504","article-title":"The management of thrombosis in the antiphospholipid-antibody syndrome","volume":"332","author":"Khamashta","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2008.07.023_bib12","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/rheumatology\/41.8.924","article-title":"A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome","volume":"41","author":"Erkan","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1053\/j.ajkd.2008.07.023_bib13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0049-0172(94)90073-6","article-title":"Systemic lupus erythematosus complicated by thrombotic microangiopathy","volume":"24","author":"Jain","year":"1994","journal-title":"Semin Arthritis Rheum"},{"key":"10.1053\/j.ajkd.2008.07.023_bib14","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/ard.2003.007245","article-title":"Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies","volume":"63","author":"Espinosa","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/j.ajkd.2008.07.023_bib15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0049-0172(94)90072-8","article-title":"Thrombotic microangiographic hemolytic anemia in systemic lupus erythematosus","volume":"24","author":"Nesher","year":"1994","journal-title":"Semin Arthritis Rheum"},{"key":"10.1053\/j.ajkd.2008.07.023_bib16","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1023\/A:1023066503209","article-title":"Anti-plasminogen autoantibodies from plasma of patients with systemic lupus erythematosus having anti-phospholipid antibody syndrome: Isolation and some immunochemical properties","volume":"68","author":"Kozmin","year":"2003","journal-title":"Biochemistry (Mosc)"},{"key":"10.1053\/j.ajkd.2008.07.023_bib17","first-page":"51","article-title":"[Anti-phospholipid syndrome nephropathy]","volume":"154","author":"Nochy","year":"2003","journal-title":"Ann Med Interne (Paris)"},{"key":"10.1053\/j.ajkd.2008.07.023_bib18","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.20433","article-title":"Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: Prevalence, clinical associations, and long-term outcome","volume":"50","author":"Tektonidou","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.ajkd.2008.07.023_bib19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1681\/ASN.V13142","article-title":"Antiphospholipid syndrome nephropathy in systemic lupus erythematosus","volume":"13","author":"Daugas","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2008.07.023_bib20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1681\/ASN.V103507","article-title":"The intrarenal vascular lesions associated with primary antiphospholipid syndrome","volume":"10","author":"Nochy","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2008.07.023_bib21","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1053\/j.ajkd.2003.09.011","article-title":"Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritis","volume":"43","author":"Moroni","year":"2004","journal-title":"Am J Kidney Dis"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638608011955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638608011955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:50:57Z","timestamp":1759456257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638608011955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0272638608011955"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2008.07.023","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombotic Microangiopathy and Renal Failure Exacerbated by \u03b5-Aminocaproic Acid","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2008.07.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}